All results
11 results for image parkinson s disease progression study
-
Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy for Limited mCRC(ERASur)
This phase III trial compares total ablative therapy and usual systemic therapy to usual systemic therapy alone in treating patients with colorectal cancer…
- Ages
- 18 Years - N/A
- Sexes
- All
-
TAK-999-3003
The main aim of this study is to learn if fazirsiran is safe during long-term use in people with liver disease caused by the abnormal Z-alpha-1 antitrypsin…
- Ages
- 18 Years - N/A
- Sexes
- All
-
Compare Chemo Before and After Surgery vs After Surgery Alone for the TX of Gallbladder Cancer
This phase II/III trial compares the effect of adding chemotherapy before and after surgery versus after surgery alone (usual treatment) in treating patients…
- Ages
- 18 Years - N/A
- Sexes
- All
-
Genomic-Risk Stratified Txs for Unfavorable Intermediate Risk Prostate Cancer (Guidance)
This phase III trial uses the Decipher risk score to guide intensification (for higher Decipher gene risk) or de-intensification (for low Decipher gene risk)…
- Ages
- 18 Years - N/A
- Sexes
- Male
-
Intravesical BCG vs GEMDOCE in NMIBC (BRIDGE)
The study hypothesis is that BCG naïve non-muscle invasive bladder cancer (NMIBC) patients treated with intravesical Gemcitabine + Docetaxel (GEMDOCE) will…
- Ages
- 18 Years - N/A
- Sexes
- All
-
Palbociclib and Binimetinib in RAS-Mutant Cancers, A ComboMATCH Treatment Trial
This phase II ComboMATCH treatment trial evaluates the effectiveness of palbociclib and binimetinib in treating patients with RAS-mutated cancers. Palbociclib…
- Ages
- 18 Years - N/A
- Sexes
- All
-
Vercise DBS Registry
The purpose of this registry is to compile characteristics of world-wide outcomes for the use of Boston Scientific's commercially available Vercise DBS System…
- Ages
- 18 Years - N/A
- Sexes
- All
-
High Risk Prostate CA: Less Intense Tx for Low Risk Scores and More Intense Tx for High Risk Scores
This phase III trial compares less intense hormone therapy and radiation therapy to usual hormone therapy and radiation therapy in treating patients with high…
- Ages
- 18 Years - N/A
- Sexes
- Male
-
Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large
This phase II trial tests whether mosunetuzumab and/or polatuzumab vedotin helps benefit patients who have received chemotherapy (fludarabine and…
- Ages
- 18 Years - N/A
- Sexes
- All
-
Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors
This phase II trial studies the effect of capecitabine and temozolomide after surgery in treating patients with high-risk well-differentiated pancreatic…
- Ages
- 18 Years - N/A
- Sexes
- All